• Return to Headlines

Lowest Return on Equity in the Pharmaceuticals Industry Detected in Shares of Neos Therapeutic (NEOS, NKTR, MDCO, IPXL, SCMP)

By Nick Russo

Below are the three companies in the Pharmaceuticals industry with the lowest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and are growing.

Neos Therapeutic ranks lowest with a ROE of -46,013.5%. Following is Nektar Therapeut with a ROE of -24,966.6%. Medicines Comp ranks third lowest with a ROE of -17,771.8%.

Impax Labs Inc follows with a ROE of -16,713.0%, and Sucampo Pha-Cl A rounds out the bottom five with a ROE of -16,361.9%.

SmarTrend recommended that subscribers consider buying shares of Sucampo Pha-Cl A on November 28th, 2017 as our technology indicated a new Uptrend was in progress when shares hit $11.18. Since that recommendation, shares of Sucampo Pha-Cl A have risen 61.1%. We continue to monitor Sucampo Pha-Cl A for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest return on equity neos therapeutic nektar therapeut medicines comp impax labs inc sucampo pha-cl a

Ticker(s): NEOS NKTR MDCO IPXL SCMP